TY - STD TI - Information Centre for Health and Social Care, NHS Contraceptive Services England 2007/08. [http://www.ic.nhs.uk/pubs/nhscontra0708.html] UR - http://www.ic.nhs.uk/pubs/nhscontra0708.html ID - ref1 ER - TY - STD TI - Schering Health Care Ltd. Mirena. [http://www.schering.co.uk] UR - http://www.schering.co.uk ID - ref2 ER - TY - STD TI - Faculty of Sexual and Reproductive Healthcare, Clinical Effectiveness Unit, FSRH Guidance (November 2007) Intrauterine Contraception. [http://www.ffprhc.org.uk/admin/uploads/CEUGuidanceIntrauterineContraceptionNov07.pdf] UR - http://www.ffprhc.org.uk/admin/uploads/CEUGuidanceIntrauterineContraceptionNov07.pdf ID - ref3 ER - TY - STD TI - National Institute for Health and Clinical Excellence (NICE). Long-acting reversible contraception: the effective and appropriate use of long - acting reversible contraception. 2005. [http://www.nice.org.uk/nicemedia/pdf/CG030fullguideline.pdf] UR - http://www.nice.org.uk/nicemedia/pdf/CG030fullguideline.pdf ID - ref4 ER - TY - JOUR AU - Harrison-Woolrych, M. AU - Ashton, J. AU - Coulter, D. PY - 2003 DA - 2003// TI - Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported? JO - Contraception VL - 67 UR - https://doi.org/10.1016/S0010-7824(02)00417-1 DO - 10.1016/S0010-7824(02)00417-1 ID - Harrison-Woolrych2003 ER - TY - BOOK PY - 1987 DA - 1987// TI - Mechanism of Action, Safety and Efficacy of Intrauterine Devices (WHO Technical Report Series No. 753) PB - WHO CY - Geneva, Switzerland ID - ref6 ER - TY - JOUR AU - Caliskan, E. AU - Öztürk, N. AU - Dilbaz, B. Ö. AU - Dilbaz, S. PY - 2003 DA - 2003// TI - Analysis of risk factors associated with uterine perforation by intrauterine devices JO - Eur J Contracept Reprod Health Care VL - 8 UR - https://doi.org/10.1080/ejc.8.3.150.155 DO - 10.1080/ejc.8.3.150.155 ID - Caliskan2003 ER - TY - JOUR AU - Zhou, L. AU - Harrison-Woolrych, M. AU - Coulter, D. M. PY - 2003 DA - 2003// TI - Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena) JO - Pharmacoepidemiol Drug Saf VL - 12 UR - https://doi.org/10.1002/pds.875 DO - 10.1002/pds.875 ID - Zhou2003 ER - TY - STD TI - Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. UK Medical Eligibility Criteria for Contraceptive Use. 2006, [http://www.ffprhc.org.uk/admin/uploads/UKMEC200506.pdf] UR - http://www.ffprhc.org.uk/admin/uploads/UKMEC200506.pdf ID - ref9 ER - TY - CHAP PY - 2007 DA - 2007// BT - BNF 54 ID - ref10 ER - TY - BOOK PY - 1999 DA - 1999// TI - The Management of Menorrhagia in Secondary Care. National Evidence- Based Clinical Guidelines PB - RCOG CY - London, UK ID - ref11 ER - TY - JOUR AU - Romer, T. AU - Schmidt, T. AU - Foth, D. PY - 2000 DA - 2000// TI - Pre- and postoperative hormonal treatment in patients with hysteroscopic surgery JO - Contributions to Gynecology and Obstetrics VL - 20 UR - https://doi.org/10.1159/000060283 DO - 10.1159/000060283 ID - Romer2000 ER - TY - STD TI - Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. Members' Enquiry Response. 2008, [http://www.ffprhc.org.uk/admin/uploads/No.2268.pdf] UR - http://www.ffprhc.org.uk/admin/uploads/No.2268.pdf ID - ref13 ER - TY - JOUR AU - Maia, H. AU - Maltez, A. AU - Coelho, G. AU - Athayde, C. AU - Coutinho, E. M. PY - 2003 DA - 2003// TI - Insertion of Mirena after Endometrial Resection in Patients with Adenomyosis JO - The Journal of the American Association of Gynecologic Laparoscopists VL - 10 UR - https://doi.org/10.1016/S1074-3804(05)60158-2 DO - 10.1016/S1074-3804(05)60158-2 ID - Maia2003 ER - TY - JOUR AU - Ozgun, M. T. AU - Batukan, C. AU - Serin, I. S. AU - Ozcelik, B. AU - Basbug, M. AU - Dolanbay, M. PY - 2007 DA - 2007// TI - Surgical management of intra-abdominal mislocated intrauterine devices JO - Contraception VL - 75 UR - https://doi.org/10.1016/j.contraception.2006.09.011 DO - 10.1016/j.contraception.2006.09.011 ID - Ozgun2007 ER -